Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2024-02-06 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
outcome of board meeting dated 06.02.2024
Interim / Quarterly Report Classification · 100% confidence The document contains detailed unaudited financial results for the quarter and nine months ended December 31, 2023, including standalone and consolidated figures. It also includes the Limited Review Report by the independent auditors, which is typical for interim financial reporting. The document mentions approval of these results by the Board of Directors and references Regulation 33 of SEBI (LODR) Regulations, 2015, which governs quarterly financial disclosures. Additionally, the document includes board meeting outcomes such as director appointments and share allotments, but the primary content is the financial results and auditor's review for the interim period. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2024
2024-02-06 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and is a regulatory compliance communication. The document is short (2189 characters) and does not contain financial statements or detailed financial data. It is not a report but an official regulatory announcement related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-02-02 English
We herewith submit the details of loss of Share Certificate as per Regulation 39(3) of SEBI (LODR) Reg, 2015.
Regulatory Filings Classification · 100% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and is a regulatory compliance communication. The document is short (2189 characters) and does not contain financial statements or detailed financial data. It is not an annual report, earnings release, or any financial report but a regulatory filing related to share certificate status. Therefore, it fits best under Regulatory Filings (RNS).
2024-02-02 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplaced/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and involves share certificate details and shareholder information. There is no financial data, earnings information, or report content. The document is a regulatory announcement related to share certificates and compliance with listing obligations, not a financial report or management information. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an official notification rather than a report or presentation.
2024-01-31 English
We herewith submit the details of loss of Share Certificate as per Regulation 39(3) of SEBI (LODR) Reg, 2015.
Regulatory Filings Classification · 100% confidence The document is an intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss/misplacement/non-receipt of share certificates and the issuance of duplicate share certificates. It is addressed to stock exchanges and is a regulatory compliance communication. The document does not contain financial statements, management discussion, or report data. It is a regulatory announcement related to share certificates, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-31 English
Board Meeting — DIAMINES & CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company f…
Regulatory Filings
2024-01-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.